BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients

BACKGROUND: A family history of prostate cancer (PrCa) is a strong risk factor for the disease, indicating that inherited factors are important in this disease. We previously estimated that about 2% of PrCa cases diagnosed ⩽55 years harbour a BRCA2 mutation and PrCa among BRCA2 carriers has been sho...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kote-Jarai, Z, Leongamornlert, D, Saunders, E, Tymrakiewicz, M, Castro, E, Mahmud, N, Guy, M, Edwards, S, O'Brien, L, Sawyer, E, Hall, A, Wilkinson, R, Dadaev, T, Goh, C, Easton, D, Goldgar, D, Eeles, R
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2011
Gaiak:
Genetics and Genomics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3208504/
https://ncbi.nlm.nih.gov/pubmed/21952622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.383
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak